| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.45 | 0.02 |